XML 14 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Interim Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary Shares
Share capital and additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total
Balance at Dec. 31, 2023   $ 86,209 $ (243) $ (67,127) $ 18,839
Balance (in Shares) at Dec. 31, 2023 5,748,018        
Share-based compensation expense   43 43
Net income   1,242 1,242
Balance at Jun. 30, 2024   86,252 (243) (65,885) 20,124
Balance (in Shares) at Jun. 30, 2024 5,748,018        
Balance at Dec. 31, 2024   86,401 (243) (64,827) $ 21,331
Balance (in Shares) at Dec. 31, 2024 5,792,559       5,792,559
Exercise of options into ordinary shares   764 $ 764
Exercise of options into ordinary shares (in Shares) 267,433        
Share-based compensation expense   21 21
Net income   2,114 2,114
Balance at Jun. 30, 2025   $ 87,186 $ (243) $ (62,713) $ 24,230
Balance (in Shares) at Jun. 30, 2025 6,059,992       6,059,992